Walgreens Story

<div class='circular--portrait' style='background:#347AFC;color: #ffffff;font-size:4em;'>WB</div>
WBA -- USA Stock  

USD 51.18  1.99  4.05%

Walgreens Boots Net Income Per Employee is projected to decrease significantly based on the last few years of reporting. The past year's Net Income Per Employee was at 1,580. The current year Average Assets is expected to grow to about 66.8 B, whereas Revenue Per Employee is forecasted to decline to about 349 K. Walgreens Boots Alli is scheduled to announce its earnings tomorrow. The upcoming quarterly report is expected on the 7th of January 2021. While some of us are excited about healthcare space, let's try to go over Walgreens Boots Alliance in greater detail to make a better evaluation of its fundamental indicators. We will evaluate if Walgreens Boots shares are reasonably priced going into February. We currently estimate Walgreens Boots as fairly valued. The real value is approaching 40.08 per share.
Published over two weeks ago
View all stories for Walgreens Boots | View All Stories
How strong are Walgreens Boots (NASDAQ:WBA) basic indicators given the current rise?
Walgreens Boots Alliance trade recommendation module can be used to check and cross-verify current trade advice provided by analysts examining the company's potential to grow using all of fundamental, technical, data market data available at the time. The company dividends can provide a clue to the current value of the stock. This firm one year expected dividend income is about $1.06 per share.
Typically, a company's financial statements are the reports that show the financial position of the company. There are three main documents that fall into the category of financial statements. These documents include Walgreens Boots income statement, its balance sheet, and the statement of cash flows. Potential Walgreens Boots investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Walgreens Boots investors may use each financial statement separately, they are all related. The changes in Walgreens Boots's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Walgreens Boots's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages. The goal of Walgreens Boots fundamental analysis is to do accurate financial forecasts. There are several possible objectives to fundamental analysis, such as projecting of Walgreens Boots performance into the future periods or doing a reasonable stock valuation. The intrinsic value of Walgreens Boots shares is the value that is considered the true value of the share. If the intrinsic value Walgreens is higher than its market price, buying is generally recommended. If it is equal to the market price, it is recommended to hold; and if it is less than the market price, then one should sell all shares Walgreens Boots. Please read more on our fundamental analysis page.

Are Walgreens Boots Earnings Expected to grow?

The future earnings power of Walgreens Boots involves the interaction of many company-specific, industry, and economic forces. Earnings estimates embody investors' opinions of Walgreens Boots factors such as sales growth, product demand, competitive industry environment, profit margins, and cost controls. Walgreens Boots stock prices adjust as these expectations change or are proven wrong. The main thing to remember is that equities with high expected earnings growth tend to underperform the market because it is usually difficult to meet the market's high expectations. Companies with low earnings expectations tend to do better than expected. Please use our latest analysis of Walgreens expected earnings.

And What about dividends?

A dividend is the distribution of a portion of Walgreens Boots earnings, decided and managed by the company's board of directors and paid to a class of its shareholders. Note, announcements of dividend payouts are generally accompanied by a proportional increase or decrease in a company's stock price. Walgreens Boots dividend payments follow a chronological order of events, and the associated dates are important to determine the shareholders who qualify for receiving the dividend payment. Walgreens one year expected dividend income is about $1.06 per share.
The current year Dividends per Basic Common Share is expected to grow to 1.42, whereas Payment of Dividends and Other Cash Distributions is forecasted to decline to (1.8 B).
Last ReportedProjected for 2021
Payment of Dividends and Other Cash Distributions-1.8 B-1.8 B
Dividend Yield 0.0162  0.0143 
Dividends per Basic Common Share 1.31  1.42 
Investing in dividend-paying stocks, such as Walgreens Boots Alliance is one of the few strategies that are good for long-term investment. Ex-dividend dates are significant because investors in Walgreens Boots must own a stock before its ex-dividend date to receive its next dividend. This type of analysis is very useful when you want to generate a past dividend schedule and payout information for Walgreens Boots. Then that information in the form of graph and calendar can be used to fully explain how Du Pont dividends can provide a real clue to its valuation.

What do experts say?

Stock analysis is a method for investors and traders to make buying and selling decisions. By studying and evaluating past and current data, investors and traders attempt to gain an edge in the markets by making informed decisions. It is good to see analyst projects for Walgreens Boots, but it might be worth checking our own buy vs. sell analysis

Walgreens Boots Gross Profit

Walgreens Boots Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Walgreens Boots previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Walgreens Boots Gross Profit growth over the last 10 years. Please check Gross Profit in more details.

Payment of 744 shares by Heather Dixon of Walgreens Boots subject to Rule 16b-3

Legal trades by Walgreens Boots insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
Walgreens insider trading alert for payment of common stock by Heather Dixon, SVP Global Controller and CAO, on 21st of December 2020. This event was filed by Walgreens Boots Alliance with SEC on 2020-09-02. Statement of changes in beneficial ownership - SEC Form 4. Heather Dixon currently serves as senior vice president chief accounting officer, global controller of Walgreens Boots Alli [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

A Deeper Perspective

Although in the United States, the Securities and Exchange Commission has enforced strong rules to prevent insiders from engaging in insider trading, finding insiders among active shareholders of Walgreens Boots is not uncomon. There are few distinct groups of Walgreens Boots stakehholders that the SEC considers insiders. Investors usually gain information through their work as corporate directors, officers, or employees. If these individuals share the information with a friend, family, or business partner and the person who receives the information exchanges stock in the company, he or shie is also an insider. Let's take a look at how the ownership of Walgreens is distributed among investors.

Ownership Allocation

Walgreens Boots Alli owns a total of 863.9 Million outstanding shares. Over half of Walgreens Boots Alli outstanding shares are owned by institutional investors. These institutional investors are typically referred to corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulation than regular investors in Walgreens Boots Alliance. Please watch out for any change in the institutional holdings of Walgreens Boots Alli as this could mean something significant has changed or about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.

Retail Investors
Retail Investors23.91
 2020 2021 (projected)
Consolidated Income3.77 B4.07 B
Direct Expenses100.37 B88.71 B

Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Walgreens Boots has an asset utilization ratio of 191.97 percent. This suggests that the company is making $1.92 for each dollar of assets. An increasing asset utilization means that Walgreens Boots Alliance is more efficient with each dollar of assets it utilizes for everyday operations.

Assets Non Current
45.5 B
25.1 B
Current Assets16.56 Billion19.01
Assets Non Current45.45 Billion52.19
Goodwill25.08 Billion28.8

Will Walgreens Boots growth be justifiable after the rise?

Current Risk Adjusted Performance is up to 0.1. Price may slip again. Walgreens Boots Alliance currently demonstrates below-verage downside deviation. It has Information Ratio of 0.05 and Jensen Alpha of 0.07. However, we do advice investors to further question Walgreens Boots Alliance expected returns to ensure all indicators are consistent with the current outlook about its relatively low value at risk.

Our Conclusion on Walgreens Boots

Whereas many other companies under the pharmaceutical retailers industry are still a bit expensive, Walgreens Boots may offer a potential longer-term growth to investors. In closing, as of the 6th of January 2021, our analysis shows that Walgreens Boots responds to the market. The company is fairly valued and projects below average probability of distress for the next 2 years. Our ongoing 30 days 'Buy-Sell' recommendation on the company is Strong Hold.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Walgreens Boots Alliance. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com